| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |